Skip to main content
Caplight Logo









Visienco

Visienco

Private
RootHealthcare & Life Scienceshttp://www.visienco.com/

Last Round

Accelerator

Feb 4, 2026

Total Funding Raised

$211,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Visienco is a biotech company that provides a standardized, scalable, and automated platform for organoid sorting and 3D model analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

lab automationorganoid handlingautomated organoid handling3D cell modelsdrug discovery toolsAI morphology analysisContract Research OrganizationCRObiotech equipmentbenchtop automationhigh-throughput screeningprecision roboticsAI microscopydigital traceabilityanimal testing alternativespersonalized medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Visienco Comparables

Compare Visienco with similar companies based on industry and business-model similarity.

Visienco comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bionomous
81%
BICO Group
77%
Sartorius Aktiengesellschaft
74%

Visienco Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 4, 2026
GrantJan 23, 2026
GrantJun 18, 2025

Visienco Investors

Notable investors and investment history

Visienco investors
InvestorRounds
W.A. de Vigier FoundationGrant
Nvidia InceptionAccelerator
Ypsomed Innovation Fund FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2026

    Received funding from Nvidia Inception.

  • Jan 23, 2026

    $64K grant from Ypsomed Innovation Fund Foundation

Visienco Filings

Explore SEC and related filing metadata, where available.

Visienco filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Visienco's valuation, stock price, and market status.

Is Visienco a public or private company?

Visienco is a private company.

What is the current stock price of Visienco?

Visienco is a private company with no public stock price. No recent secondary market data is available.

How much is Visienco worth (valuation)?

Valuation information for Visienco is not publicly available.

Can I buy Visienco stock?

Visienco shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Visienco's last funding round?

Visienco's most recent funding round was Accelerator on February 4, 2026.

Who are the main investors in Visienco?

Key investors in Visienco include W.A. de Vigier Foundation, Nvidia Inception, Ypsomed Innovation Fund Foundation.

Will Visienco IPO soon?

No public IPO plans have been announced for Visienco.

How can I track Visienco secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Visienco's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRoot
Year Founded2025
Last FundingFeb 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?